Epstein-Barr virus strains with latent membrane protein-1 deletions: Prevalence in the italian population and high association with human immunodeficiency virus-related Hodgkin's disease

Blood

Volumn 89, Issue 5, 1997, Pages 1723-1731

  Dolcetti, Riccardo ^b   Zancai, Paola ^b   De Re, Valli ^b   Gloghini, Annunziata ^b   Bigoni, Beatrice ^b   Pivetta, Barbara ^b   De Vita, Salvatore ^b   Carbone, Antonino ^b   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE ACTIVATION; CARBOXY TERMINAL SEQUENCE; CELL IMMORTALIZATION; DELETION MUTANT; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE DELETION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LYMPHADENOPATHY; MONONUCLEAR CELL; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0031035336     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1723.1723_1723_1731     Document Type: Article

References (46)

1. Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702, 1964
2. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L: EBV DNA in biopsies of Burkitt's lymphoma and anaplastic carcinoma of the nasopharynx. Nature 228:1056, 1970
3. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J: Epstein-Barr viral DNA in tissue of Hodgkin's disease. Am J Pathol 129:86, 1987
4. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS: Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation. Clinical, pathological, and virological findings and implications for therapy. Ann Surg 198:356, 1983
5. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhøj P, Pedersen C: AIDS related lymphomas. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridisation. Am J Pathol 138:149, 1991
6. Pallesen G, Hamilton-Dutoit SJ, Zhou XG: The association of Epstein-Barr virus (EBV) with T cell lymphoproliferation and Hodgkin's disease: Two new developments in the EBV field. Adv Cancer Res 62:179, 1993
7. Young L, Dawson C, Clark D, Rupani H, Busson P, Turz T, Johnsson A, Rickinson A: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051, 1988
8. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young L: Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 2:320, 1991
9. Kaye KM, Isuzmi KM, Kieff E: Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150, 1993
10. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson AB, Larson R, Springer T, Kieff E: Epstein-Barr latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J Virol 62:4173, 1988
11. Peng M, Lundgren E: Transient expression of the Epstein-Barr virus LMP-1 gene in chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: Cell-type independent-induction of CD23, CD21 and ICAM-1. Leukemia 7:104, 1993
12. Calendar A, Billaud M, Aubry J, Banchereau J, Vuillaume M, Lenoir G: EBV induces expression of B cell activation markers on in vitro infection of EBV negative B lymphoma cells. Proc Natl Acad Sci USA 84:8060, 1987
13. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
14. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1985
15. Fåhraeus R, Rymo L, Rhim JS, Klein G: Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447, 1990
16. Dawson CW, Rickinson AB, Young LS: Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777, 1990
17. Hudson GS, Farrel PJ, Barrel BG: Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 53:528, 1985
18. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G: Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937, 1993
19. Sandvej K, Peh S-C, Andresen BS, Pallesen G: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053, 1994
20. Santón A, Manzanal AI, Campo E, Bellas C: Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol Mol Pathol 48:M184, 1995
21. Knecht H, Martins F, Bachmann E, Hoffman T, Zimmermann DR, Rothenberger S, Sandvej K, Wegmann W, Hurwitz N, Odermatt B, Kummer H, Pallesen G: A deletion mutant of the LMP-1 oncogene of Epstein-Barr virus is associated with evolution of angioim-munoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 9:458, 1995
22. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523, 1995
23. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399, 1991
24. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131, 1992
25. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575, 1993
26. Trivedi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G: Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a naso pharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 30A:84, 1994
27. + population. Science 260:98, 1993
28. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
29. Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 12:433, 1988
30. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M: Human-immunodeficiency-virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr-viral-latent gene expression. J Clin Oncol 11:1674, 1993
31. Boiocchi M, De Re V, Gloghini A, Vaccher E, Dolcetti R, Marzotto A, Bertola G, Carbone A: High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell Ki-1-positive lymphomas in HIV-1-positive patients. Int J Cancer 54:53, 1993
32. Lewin N, Åman P, Åkerlund B, Gustavsson E, Carenfelt C, Lejdeborn L, Klein G, Klein E: Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Immunol Lett 26:59, 1990
33. Rab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883, 1986
34. Knecht H, Bachmann E, Joske DJL, Sahli R, Emery-Good-man A, Casanova JL, Zilic M, Bachmann F, Odermatt BF: Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 7:580, 1993
35. Dolcetti R, Gloghini A, De Vita S, Vaccher V, De Re V, Tirelli U, Carbone A, Boiocchi M: Characteristics of EBV-infected cells in HIV-related lymphadenopathy: Implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals. Int J Cancer 63:652, 1995
36. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrel PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PS, Barrell BG: DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207, 1984
37. Frisan T, Sjöberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A, Brautbar C, Battat S, Biberfeld M, Eckman M, Öst Å, Christensson B, Sundström C, Björkholm M, Pisa P, Masucci MG: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493, 1995
38. Chen W-G, Chen Y-Y, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM: Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 148:17, 1996
39. Vasef MA, Kamel OW, Chen Y-Y, Medeiros LJ, Weiss LM: Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 147:1408, 1995
40. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB: The Epstein-Barr virus carrier state: Dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 72:1579, 1991
41. Birx DI, Redfield RR, Tosato G: Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 14:874, 1986
42. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA: Co-infection with A- and B-type Epstein-Barr virus in human-immunodeficiency-virus-positive subjects. J Infect Dis 162:643, 1990
43. Moorthy RK, Thorley-Lawson DA: All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblasts. J Virol 67:1638, 1993
44. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, Franceschi S, Boiocchi M, Carbone A: Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and tumors. J Clin Oncol 13:1758, 1995
45. Miller WE, Edwards RH, Walling DM, Raab-Traub N: Sequence variation in the Epstein-Barr virus latent membrane protein1. J Gen Virol 75:2729, 1994
46. Rickinson AB, Young LS, Rowe M: Influence of the Epstein-Barr-virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B-cells. J Virol 61:1310, 1987